Lumida
/BBIO
⌘K
BridgeBio Pharma Inc

BridgeBio Pharma Inc

BBIO
$72.44USD-0.08%-0.06 today

MARKET CAP

14.2B

P/E (TTM)

FWD P/E

DAY RANGE

$72 – $74

52W RANGE

$49
$93

AI Summary

Stalk
Buy NowMedium

BBIO is deeply oversold around its 200 DMA support after a sharp downtrend, and mean-reversion eligibility forces a medium-term bullish bias. Short-term price extension below declining EMAs at extreme OS levels suggests a tactical entry opportunity as price stabilizes near support, warranting a Buy Now execution on a pullback into this major structural zone.

  • Phase 3 acoramidis trial shows reversal of cardiac changes in ATTR-CM
  • Infigratinib Phase 3 PROPEL 3 trial positive in achondroplasia, NDA filing planned
  • Negative earnings yield and low book-to-price signal possible overvaluation
Full analysis →

Buying

13

institutions

Selling

8

institutions

New Positions

1

this quarter

Filing Period

Q1 2026

latest 13-F

13-F Holdings

InstitutionActionShares HeldValueChangeChg %Weight
JH

Janus Henderson Group Plc

Q1 2026

BUY26.36 M1.96 B+15.36 M+132.6%0.48%
FC

Farallon Capital Management, L.l.c.

Q2 2026

BUYNEW10.74 M800.14 M+10.74 M+0.0%3.72%
BI

Blackrock, Inc.

Q2 2026

SELL10.29 M766.19 M+-3.92 M-27.4%0.01%
VG

Viking Global Investors LP

Q2 2026

SELL9.95 M741.02 M+-1.89 M-15.7%2.11%
FC

Farallon Capital Management LLC

Q1 2026

BUY9.37 M695.48 M+367.00 K+1.0%0.00%
CA

Citadel Advisors LLC

Q2 2026

BUY4.33 M322.27 M+936.69 K+28.0%0.04%
JC

Jpmorgan Chase & Co

Q2 2026

BUY2.40 M173.23 M+1.09 M+90.3%0.01%
PA

Point72 Asset Management, L.P.

Q2 2026

BUY1.53 M114.16 M+1.49 M+3157.0%0.13%
BA

Balyasny Asset Management L.P.

Q2 2026

BUY1.23 M91.61 M+879.96 K+252.4%0.12%
RT

Renaissance Technologies LLC

Q2 2026

BUY856.85 K63.82 M+491.07 K+134.9%0.09%
MM

Millennium Management LLC

Q2 2026

BUY669.79 K49.89 M+36.51 K+6.1%0.02%
BA

Bridgewater Associates, LP

Q2 2026

BUY448.14 K33.38 M+188.68 K+73.2%0.14%
FA

Fisher Asset Management, LLC

Q2 2026

SELL345.35 K25.72 M+-6.28 K-1.5%0.01%
WP

Woodline Partners LP

Q2 2026

SELL301.31 K22.44 M+-300.71 K-49.8%0.07%
CP

California Public Employees Retirement System

Q2 2026

SELL194.87 K14.51 M+-58.61 K-22.9%0.01%
AC

Adar1 Capital Management, LLC

Q2 2026

BUY176.69 K13.16 M+82.40 K+87.9%0.61%
AC

Aqr Capital Management LLC

Q2 2026

BUY166.95 K12.43 M+6.84 K+4.6%0.00%
BH

Brevan Howard Capital Management LP

Q2 2026

BUY155.73 K11.60 M+74.16 K+91.5%0.09%
RC

Rockefeller Capital Management L.P.

Q2 2026

SELL45.32 K3.38 M+-8.30 K-15.2%0.01%
MG

Man Group Plc

Q2 2026

SELL27.53 K2.05 M+-681.00-2.1%0.00%
VI

Voloridge Investment Management, LLC

Q2 2026

SELL0.000.00+-426.58 K-100.0%0.00%